Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients.

Nieminen U, Peltola H, Syrjälä MT, Mäkipernaa A, Kekomäki R.

Acta Paediatr. 1993 Mar;82(3):267-70.

PMID:
8495082
2.

The Vaccine Adverse Event Reporting System (VAERS).

Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, Wassilak SG.

Vaccine. 1994 May;12(6):542-50.

PMID:
8036829
3.

Surveillance of the safety of simultaneous administration of vaccines. The Centers for Disease Control and Prevention experience.

Chen RT, Haber P, Mullen JR.

Ann N Y Acad Sci. 1995 May 31;754:309-20. Review. No abstract available.

PMID:
7625667
4.

Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR.

Pediatrics. 1981 Nov;68(5):650-60.

PMID:
7031583
5.

A 7-year survey of disorders attributed to vaccination in North West Thames region.

Pollock TM, Morris J.

Lancet. 1983 Apr 2;1(8327):753-7.

PMID:
6132093
6.

Post-vaccination symptoms following DTP and DT vaccination.

Pollock TM, Miller E, Mortimer JY, Smith G.

Dev Biol Stand. 1985;61:407-10.

PMID:
3879685
7.

History of convulsions and use of pertussis vaccine.

Stetler HC, Orenstein WA, Bart KJ, Brink EW, Brennan JP, Hinman AR.

J Pediatr. 1985 Aug;107(2):175-9.

PMID:
3874940
8.

Food and Drug Administration monitoring of adverse drug reactions.

Sills JM, Tanner LA, Milstien JB.

Am J Hosp Pharm. 1986 Nov;43(11):2764-70.

PMID:
3799612
9.

Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome.

Walker AM, Jick H, Perera DR, Thompson RS, Knauss TA.

Am J Public Health. 1987 Aug;77(8):945-51.

10.

Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.

Deforest A, Long SS, Lischner HW, Girone JA, Clark JL, Srinivasan R, Maguire TG, Diamond SA, Schiller RP, Rothstein EP, et al.

Pediatrics. 1988 Feb;81(2):237-46.

PMID:
3340474
11.

Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination.

Cochi SL, Edmonds LE, Dyer K, Greaves WL, Marks JS, Rovira EZ, Preblud SR, Orenstein WA.

Am J Epidemiol. 1989 Feb;129(2):349-61.

PMID:
2912045
12.

Monitoring system for adverse events following immunization.

Stetler HC, Mullen JR, Brennan JP, Livengood JR, Orenstein WA, Hinman AR.

Vaccine. 1987 Sep;5(3):169-74.

PMID:
2823494
13.

Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984.

Sutter RW, Cochi SL, Brink EW, Sirotkin BI.

Am J Epidemiol. 1990 Jan;131(1):132-42.

PMID:
2403465
14.

Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ Jr, Green M, Andrews LG, Faich GA.

JAMA. 1990 Apr 4;263(13):1785-8.

PMID:
2313850
15.
16.

Risk of seizures after measles-mumps-rubella immunization.

Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W.

Pediatrics. 1991 Nov;88(5):881-5.

PMID:
1945626
17.

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.

Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, Pallansch MA, Orenstein WA, Hinman AR.

Clin Infect Dis. 1992 Feb;14(2):568-79. Review.

PMID:
1554844

Supplemental Content

Support Center